Studies how nerves raise blood pressure in obesity-linked high blood pressure
Studies nerve signals and blood vessel response in adults with obesity and high blood pressure.
Key facts
- Who runs it
- University of Texas Southwestern Medical Center
- Where
- Dallas, United StatesSee the site
- Trial code
- Registry title
- Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
- Status
- Recruiting
- Phase
- Early phase 1
- People taking part
- 100 people, planned
- Started
- 18 Jul 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 4 groups
- Treatments tested
- Neuropeptide Y
- Record updated
- 3 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 55 in four groups: healthy controls, people with high blood pressure, people with obesity, and people with both obesity and high blood pressure.
- Age
- 18 to 55 years
- Sex
- All sexes can join.
- Disease stage
- Four groups. Control: BMI under 30. Hypertensive: BMI under 30 and high blood pressure confirmed by 24-hour ambulatory blood pressure monitoring. Obese: BMI over 30. Obese-hypertensive: BMI over 30 and high blood pressure confirmed by 24-hour ambulatory blood pressure monitoring.
Main reasons for not taking part
- Other significant cardiovascular disease
- Kidney disease
- History of smoking
- Diabetes
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Control - BMI<30, age 18-55
- Hypertensive - BMI<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI>30, age 18-55 Obese-hypertensive- BMI>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring
Who cannot take part
- All groups - presence of other significant cardiovascular disease, renal disease, history of smoking, diabetes,
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
Where in United States
- University of Texas Southwestern Medical CenterDallas, United StatesContact: CHristopher HearonTaking people
About the trial
What the trial wants to find out
The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.
The 4 groups in the trial
- Healthy ControlTreatment being tested
Healthy age matched controls with no history of cardiovascular disease and normal bodyweight
Treatment: Neuropeptide Y
- HypertensiveTreatment being tested
Hypertensive adults who are not obese
Treatment: Neuropeptide Y
- ObeseTreatment being tested
Obese adults who are not hypertensive
Treatment: Neuropeptide Y
- Obese-hypertensiveTreatment being tested
Obese adults who are being treated for hypertension
Treatment: Neuropeptide Y
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension
- Plain-language title
- Studies how nerves raise blood pressure in obesity-linked high blood pressureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04838678, who can take part
- Record updated
- 3 September 2026